Delivery Order SPE2DR25D2206-SPE2DR26F9WT8
Award Date 3/18/26
Potential Completion Date 3/19/26
Potential Value $27K
Federal Agency
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency issued a $21,649.09 delivery order to Amerisourcebergen Drug Corp on March 6, 2026, for supply of Everolimus 1 mg tablets (60-count units), with an ultimate completion date of March 9, 2026. The order is issued under the company's Indefinite Delivery Contract with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026, which serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs. Place of performance is...
- The Defense Logistics Agency issued a $12,749.86 delivery order to Amerisourcebergen Drug Corp on March 18, 2026, for Everolimus 10 mg tablets (30 count). The order is firm fixed price with an ultimate completion date of March 19, 2026 and is performed in Conshohocken, PA. The delivery order is issued under the DLA Troop Support Medical Indefinite Delivery Contract (IDC) valued at $999,999,999.00 through December 2026, which serves as a comprehensive global pharmaceutical support vehicle...
- The Defense Logistics Agency issued a delivery order to AmerisourceBergen Drug Corp on March 13, 2026, for Everolimus 5 mg tablets (30-count units) with a ceiling value of $10,946.76 under a firm fixed-price structure. The order is issued under the DLA Troop Support Medical Indefinite Delivery Contract (valued at up to $999,999,999.00 through December 2026), which serves as a comprehensive global pharmaceutical support vehicle enabling supply of a wide range of pharmaceutical products and...
- The Defense Logistics Agency issued a $9,124.98 delivery order to Amerisourcebergen Drug Corp on March 3, 2026, for Everolimus 0.5 mg tablets (60-count packages), with an ultimate completion date of March 4, 2026. The order is issued under the DLA Troop Support Medical indefinite delivery contract (SPE2DX), valued at $999,999,999.00 through December 2026, which serves as a comprehensive global pharmaceutical support vehicle enabling supply of a broad range of pharmaceutical products and...
- <p>The Defense Logistics Agency issued a $17,995.64 delivery order to Amerisourcebergen Drug Corp on March 11, 2026, for Everolimus 1 mg tablet UD 60s, with ultimate completion on March 12, 2026.</p> <p>The order is issued under the DLA Troop Support Medical IDC (SPE2DX), a comprehensive global pharmaceutical support vehicle valued at $999,999,999 through December 2026. Place of performance is Conshohocken, PA. Pricing is firm fixed price with no set-aside applied.</p>
- The Defense Logistics Agency issued a $29,836.88 delivery order to Amerisourcebergen Drug Corp on February 10, 2026, for supply of Everolimus 10 mg tablets (30-count). The order is placed against the DLA Troop Support Medical Indefinite Delivery Contract, a $999,999,999.00 vehicle running through December 2026 that provides pharmaceutical and medical supply support to military healthcare programs worldwide. Place of performance is Conshohocken, PA. Ultimate completion date is February 11,...
- <p>The Defense Logistics Agency issued a delivery order to Amerisourcebergen Drug Corp on February 18, 2026, with a ceiling value of $16,420.11 for Everolimus 5 mg tablets (30-count units).</p> <p>Place of performance is Conshohocken, PA. The order has a firm fixed price structure with an ultimate completion date of February 19, 2026.</p>
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 29, 2025, for the supply of Everolimus 1 mg tablets in unit dose packaging (60 count) with a ceiling value of $4,250.58. This is a firm fixed price delivery order with no set-aside designation, indicating the award was competitively procured. The order is scheduled for ultimate completion by December 30, 2025, and will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a $3,978.63 delivery order to AmerisourceBergen Drug Corp on July 30, 2025, for the supply of Everolimus 1 mg tablets in unit dose packaging (60 count). This is a firm fixed price, competitively awarded contract with no set-aside designation and a completion date of July 31, 2025. The pharmaceutical product will be delivered to the contractor's location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen Drug Corp's larger...
- The Defense Logistics Agency awarded a delivery order valued at $6,374.93 to AmerisourceBergen Drug Corp for Everolimus 10 mg tablets (30-count units) on December 8, 2025, with completion expected by December 9, 2025. This firm fixed-price delivery order represents a competitive award with no set-aside designation and is being performed at the contractor's facility in Conshohocken, Pennsylvania. Everolimus is an immunosuppressant and anticancer medication used in various medical applications,...
- SPE2DR25D2206Indefinite Delivery Contract
- SPE2DR25D2206-SPE2DR26F9WT8Delivery Order
The Defense Logistics Agency issued a $26,618.90 delivery order to Amerisourcebergen Drug Corp on March 18, 2026, for Everolimus 10 mg tablets (30-count). The order is issued under the parent Indefinite Delivery Contract with the Defense Logistics Agency Troop Support Medical, valued at up to $999,999,999.00 and running through December 2026. This IDC provides global pharmaceutical support to military healthcare programs, covering a comprehensive range of pharmaceutical products and medical supplies. Place of performance is Conshohocken, Pennsylvania. The order carries a firm fixed price, with ultimate completion scheduled for March 19, 2026. No set-aside applied to this award.
Generated 6/17/26, 10:49 AM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $26.6k | 3/17/26 |